Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 September 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 189 pages)

 

Export 6 results:
Author Title Type [ Year(Asc)]
Filters: Author is Gadalla, S. M.  [Clear All Filters]
2018
D. B. Wolfson, Best, A. F., Addona, V., Wolfson, J., and Gadalla, S. M., Benefits of combining prevalent and incident cohorts: An application to myotonic dystrophy, Stat Methods Med Res, p. 962280218804275, 2018.
R. Alsaggaf, St George, D. M. M., Zhan, M., Pfeiffer, R. M., Wang, Y., Wagner, K. R., Greene, M. H., Amr, S., and Gadalla, S. M., Cancer Risk in Myotonic Dystrophy Type I: Evidence of a Role for Disease Severity, JNCI Cancer Spectr, vol. 2, p. pky052, 2018.
P. Karimi, Birmann, B. M., Anderson, L. A., McShane, C. M., Gadalla, S. M., Sampson, J. N., and Mbulaiteye, S. M., Risk factors for Burkitt lymphoma: a nested case-control study in the UK Clinical Practice Research Datalink, Br J Haematol, vol. 181, pp. 505-514, 2018.
Y. Wang, Pfeiffer, R. M., Alsaggaf, R., Meeraus, W., Gage, J. C., Anderson, L. A., Bremer, R. C., Nikolenko, N., Lochmuller, H., Greene, M. H., and Gadalla, S. M., Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research Datalink, Int J Cancer, vol. 142, pp. 1174-1181, 2018.
Z. Liu, Alsaggaf, R., McGlynn, K. A., Anderson, L. A., Tsai, H. T., Zhu, B., Zhu, Y., Mbulaiteye, S. M., Gadalla, S. M., and Koshiol, J., Statin use and reduced risk of biliary tract cancers in the UK Clinical Practice Research Datalink, Gut, 2018.
[Page last reviewed 6 September 2019]